BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 35289141)

  • 1. A Case Report for Using Methylprednisolone for Severe ARDS Caused by SARS-CoV-2 Delta Variant in a Pediatric Patient With Lennox-Gastaut Syndrome.
    Park E; You J
    J Korean Med Sci; 2022 Mar; 37(10):e82. PubMed ID: 35289141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study.
    Monreal E; Sainz de la Maza S; Natera-Villalba E; Beltrán-Corbellini Á; Rodríguez-Jorge F; Fernández-Velasco JI; Walo-Delgado P; Muriel A; Zamora J; Alonso-Canovas A; Fortún J; Manzano L; Montero-Errasquín B; Costa-Frossard L; Masjuan J; Villar LM;
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):761-769. PubMed ID: 33083917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel coronavirus disease (COVID-19) complicated by pulmonary embolism and acute respiratory distress syndrome.
    Li T; Cheng GS; Pipavath SNJ; Kicska GA; Liu L; Kinahan PE; Wu W
    J Med Virol; 2020 Oct; 92(10):2205-2208. PubMed ID: 32470156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of pediatric patients with acute respiratory distress syndrome due to COVID-19.
    Marroquín-Yáñez ML; Medeiros M; Chávez-López A; Carrillo-López HA; Soto-Bautista NP; Jarillo-Quijada AE; Gómez-Murillo SY; Láscari-Jiménez EC; Ruiz-Quiñones G; Barrera-Alonzo CJ; Contras-Santiago EM; Hernández-Hernández M
    Bol Med Hosp Infant Mex; 2022; 79(3):170-179. PubMed ID: 35882022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
    Ting CT; Chen BS
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus.
    Sukhdeo S; Negroponte E; Rajasekhar H; Gaur S; Horton DB; Malhotra A; Moorthy LN
    Lupus; 2021 Apr; 30(5):836-839. PubMed ID: 33509065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and non-COVID ARDS patients demonstrate a distinct response to low dose steroids- A retrospective observational study.
    Longobardo A; Snow TAC; Montanari C; Shulman R; Singer M; Arulkumaran N
    J Crit Care; 2021 Apr; 62():46-48. PubMed ID: 33260010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view.
    Berton AM; Prencipe N; Giordano R; Ghigo E; Grottoli S
    J Endocrinol Invest; 2021 Apr; 44(4):873-875. PubMed ID: 32514902
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of a critically ill patient with acute respiratory distress syndrome from COVID-19 using mechanical ventilation strategy with low levels of positive end-expiratory pressure: A CARE-compliant case report.
    Guo WG; Fang B; Xian YS; Yu ZH; Zhou LX
    Medicine (Baltimore); 2020 Dec; 99(49):e23160. PubMed ID: 33285690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19.
    Sahebnasagh A; Mojtahedzadeh M; Najmeddin F; Najafi A; Safdari M; Rezai Ghaleno H; Habtemariam S; Berindan-Neagoe I; Nabavi SM
    Arch Med Res; 2020 Oct; 51(7):631-635. PubMed ID: 32863034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocilizumab for the Treatment of COVID-19-Induced Cytokine Storm and Acute Respiratory Distress Syndrome: A Case Series From a Rural Level 1 Trauma Center in Western Pennsylvania.
    Suresh K; Figart M; Formeck S; Mehmood T; Abdel Salam M; Bassilly D
    J Investig Med High Impact Case Rep; 2021; 9():23247096211019557. PubMed ID: 34105382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comprehensive Review of Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome.
    Khiali S; Khani E; Entezari-Maleki T
    J Clin Pharmacol; 2020 Sep; 60(9):1131-1146. PubMed ID: 32557541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of inhaled nitric oxide in COVID-19-induced ARDS - Is it worthwhile?
    Lotz C; Muellenbach RM; Meybohm P; Mutlak H; Lepper PM; Rolfes CB; Peivandi A; Stumpner J; Kredel M; Kranke P; Torje I; Reyher C
    Acta Anaesthesiol Scand; 2021 May; 65(5):629-632. PubMed ID: 33296498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Likelihood of amyloid formation in COVID-19-induced ARDS.
    Sinha N; Thakur AK
    Trends Microbiol; 2021 Nov; 29(11):967-969. PubMed ID: 33795156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylprednisolone use in children with severe pneumonia caused by severe acute respiratory syndrome coronavirus 2.
    Ozsurekci Y; Aykac K; Demir OO; Ilbay S; Kesici S; Karakaya J; Cengiz AB
    Pediatr Int; 2023; 65(1):e15603. PubMed ID: 37615374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Clinical Course of COVID-19 Pneumonia and Acute Respiratory Distress Syndrome in 2 Passengers from the Cruise Ship Diamond Princess in February 2020.
    Matsumura K; Toyoda Y; Matsumoto S; Kawai Y; Mori T; Omasa K; Fukada T; Yamada M; Kazamaki T; Furugori S; Hiroe N; Senoo S; Shimizu M; Funabiki T; Yamazaki M
    Am J Case Rep; 2020 Aug; 21():e926835. PubMed ID: 32811804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay.
    Galassi G; Marchioni A
    Acta Neurol Belg; 2021 Jun; 121(3):633-642. PubMed ID: 33811309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
    Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
    JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale.
    Kosanovic D; Yaroshetskiy AI; Tsareva NA; Merzhoeva ZM; Trushenko NV; Nekludova GV; Schermuly RT; Avdeev SN
    Int J Infect Dis; 2021 Mar; 104():108-110. PubMed ID: 33352323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.